Jump to content
Powered by

Selected press releases

  • Press release - 04/12/2012

    The regulation of important signal molecules that are critical for the formation of various cell types can be influenced by a chemically produced variant of indirubin, a natural material used in traditional Chinese medicine. This was shown by scientists from Heidelberg University, Kaiserslautern and Jena. The researchers were also able to demonstrate for the first time that these signal molecules in the cell – regulatory SMAD proteins – are not…

  • Press release - 04/12/2012

    Neurobiologists from Heidelberg University’s Centre for Organismal Studies (COS) have gained new insights into how different types of nerve cells are formed in the developing animal. Through specialised microscopes, they were able to follow the development of the neural retina in the eye of living zebrafish embryos. Using high-resolution three-dimensional time-lapse images the researchers simultaneously observed the division of retinal nerve…

  • Press release - 29/11/2012

    While in deep dreamless sleep, our hippocampus sends messages to our cortex and changes its plasticity, possibly transferring recently acquired knowledge to long-term memory. But how exactly is this done? Scientists from the Max Planck Institute for Biological Cybernetics have now developed a novel multimodal methodology called "neural event-triggered functional magnetic resonance imaging" (NET-fMRI) and presented the very first results…

  • Press release - 26/11/2012

    The cortex consists of six different layers, which vary in their anatomical and physiological properties. It plays a key role in the cognitive capacities of the brain. Since the cortical layers are segregated functionally, we could potentially say something about the neural processes that take place when an area is activated if we could see different signals in the different layers. Jozien Goense from the Max Planck Institute for Biological…

  • Press release - 26/11/2012

    Immobile patients are in constant danger of developing pressure ulcers on the skin. Empa, Schoeller Medical and the Swiss Paraplegic Centre have worked together to develop a special sheet that is gentle on the skin and helps to make patients more comfortable.

  • Press release - 26/11/2012

    An estimated 220 million people become infected with malaria each year. The disease is often lethal – particularly in tropical developing countries with insufficient health care services. The infected suffer from a high fever. As this is also the case with other germs, however, it is important to conduct a rapid and precise analysis to determine the cause of the disease for a successful therapy. A team of researchers aims to develop a rapid test…

  • Press release - 22/11/2012

    Clumped proteins can be dissolved with the aid of cellular repair systems – a process of critical importance for cell survival especially under conditions of stress. Heidelberg researchers have now decrypted the fundamental mechanism for dissolving protein aggregates that involves specific molecular chaperones. Scientists from the Center for Molecular Biology of Heidelberg University and the German Cancer Research Center cooperated with experts…

  • Press release - 16/11/2012

    Prof. Dr. Michael Reth, professor of Molecular Immunology at the Institute of Biology III, speaker of the excellence cluster Centre for Biological Signaling Studies BIOSS and group leader at the Max Planck Institute of Immunobiology and Epigenetics in Freiburg, has been awarded an Advanced Grant of the European Research Council (ERC). The 2.24 million Euro award will be used to fund research over the next 5 years. The Albert-Ludwigs-University…

  • Press release - 15/11/2012

    Yersinia enterocolitica, a pathogenic bacterium, causes fever and diarrhea. By help of a protein anchored in its membrane, Yersinia attaches to its host cells and infects them. Scientists of the Max Planck Institute for Developmental Biology in Tübingen and the Leibniz-Institut fuer Molekulare Pharmakologie in Berlin have determined the structure of an important component of the membrane protein and have gained insight into its biogenesis. The…

  • Press release - 13/11/2012

    immatics biotechnologies GmbH, a biopharmaceutical company developing rationally designed therapeutic vaccines that are active against cancer, announced that it has completed patient recruitment into the pivotal phase 3 trial evaluating its lead cancer vaccine IMA901 for renal cell carcinoma (RCC). The trial has completed patient inclusion and it is expected that around 345 patients will be randomized across 10 countries in the US and Europe. The…

  • Press release - 12/11/2012

    The 1000 Genomes Project presents a map of normal human genetic variation – everything from tiny changes in the genetic code to major alterations in our chromosomes. In a DNA version of ‘spot-the-difference’, EMBL scientists and their colleagues studied the genomes of 1092 healthy people from Europe, the Americas and East Asia, systematically tracking what makes us different from each other. Their results, published in Nature, open new approaches…

Website address: https://www.gesundheitsindustrie-bw.de/en/article/press-release